This inventor holds 6 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Academia Sinica, Immunwork Inc., Other. Active years: 2017-2021.
Company Filing History:
2 out of 726 
2 out of 12 
2 out of 834,411 Years Active: 2017-2021
Title: Chien-Jen Lin: Innovator in Pharmaceutical Constructs
Introduction
Chien-Jen Lin is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of molecular constructs aimed at treating various diseases. With a total of six patents to his name, Lin's work showcases his dedication to advancing medical science.
Latest Patents
Among his latest patents, Lin has developed pharmaceutical constructs with enhanced binding affinity with albumin. This innovation provides various molecular constructs that incorporate a plurality of fatty acids and a functional element. Additionally, he has created molecular constructs for treating tumors, which include a targeting element and an effector element. These constructs are designed to improve treatment methods for various diseases.
Career Highlights
Chien-Jen Lin has worked at Academia Sinica, a leading research institution in Taiwan. His role there has allowed him to engage in groundbreaking research and development in the pharmaceutical sector. His contributions have been instrumental in pushing the boundaries of what is possible in medical treatments.
Collaborations
Lin has collaborated with notable colleagues, including Tse-Wen Chang and Hsing-Mao Chu. These partnerships have fostered an environment of innovation and have led to the successful development of his patented technologies.
Conclusion
Chien-Jen Lin's work in pharmaceutical constructs exemplifies the impact of innovative thinking in medicine. His patents reflect a commitment to improving health outcomes through advanced research and collaboration. His contributions continue to influence the field and inspire future innovations.